Innovation + Divide...
Health Care: Drugs
Acura Pharmaceuticals Inc. (ACUR: NASDAQ)
$3.24 0.01 | 0.31%
02/09/12 - 04:00 PM ET
65.48K / 68.00K
Vol / Avg. Vol:3.25 / 3.23
Open / Prev. Close:3.20 - 3.31
Today's Range:2.28 - 6.80
52 Wk Range:-7.45%
Performance YTD:TheStreet Rating:
Portfolios with ACUR
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE HOT STOCKS (BUY ...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- User©SUPRATRADE HOT STOCKS (...
- UserBald Jesse's
- UserAsianenigma portofolio
- Userrvood Portfolio 1
Latest ACUR Headlines from TheStreet
- 7 Stocks Under $10 Moving Higher 11.30.11 | 12:11 pm
- Acura Stock Soars (ACUR) 09.30.11 | 02:09 pm
- Acura Stock Soars (ACUR) 08.15.11 | 12:08 pm
- Acura Pharmaceuticals Inc. Stock Upgraded (ACUR) 08.03.11 | 07:08 am
- Pfizer, Pain Therapeutics Drug Rejected by FDA 06.24.11 | 08:06 am
- Small-Cap Spotlight: Dex One, Acura Pharma 06.20.11 | 02:06 pm
- A Busy Week for Six Biotech Stocks 06.20.11 | 06:06 am
- Pfizer, Acura Painkiller Approved by FDA 06.19.11 | 04:06 pm
- Acura Pharmaceuticals Reports Year-End And Fourth Quarter 2010 Financial Results And Product Development Update 03.01.11 | 04:03 pm
- ACUROX(R) Tablets New Drug Application Accepted For Filing With A Priority Review Classification 02.14.11 | 06:02 am
Press Releases for ACUR
- Pfizer And Acura Announce FDA Approval Of Oxectatm (Oxycodone HCL, USP) CII - Business Wire 06.20.11 | 07:06 am
- Kahn Swick & Foti, LLC And Former Louisiana State Attorney General Remind Investors With Large Financial Interests (Over $100,000) Of Important 11/9/2010 Deadline In Securities Class Action Against Acura Pharmaceuticals, Inc. - ACUR - Business Wire 11.03.10 | 05:11 pm
- The Shuman Law Firm Announces The Filing Of A Class Action Lawsuit Against Acura Pharmaceuticals, Inc. - Business Wire 10.21.10 | 02:10 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 08:09 pm
- Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 07:09 pm
- The Law Office Of Robbins Umeda LLP Announces The Filing Of A Class Action Suit Against Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 06:09 pm
- Law Office Of Jonathan M. Stein, P.L. Investigates Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Acura Pharmaceuticals, Inc. - Business Wire 09.14.10 | 03:09 pm
Partner Headlines for ACUR
- 10 Biotech Stocks With 100% Upside In 2012: Part One - Seeking Alpha 02.09.12 | 10:02 am
- Building The Perfect Portfolio: Best Small Cap Stocks - Seeking Alpha 12.02.11 | 08:12 am
- Insider Buys May Send The Wrong Signals - Seeking Alpha 08.22.11 | 09:08 am
- Company News for June 21, 2011 - Corporate Summary - Zacks 06.21.11 | 10:06 am
- Acura Pharmaceuticals: FDA's Drug Decision Friday May Unlock Big Opportunity - Seeking Alpha 06.15.11 | 09:06 am
- 12 Healthcare Companies Looking at June Catalysts - Seeking Alpha 05.30.11 | 04:05 am
- King Pharma Files NDA for Pain Drug - Analyst Blog - Zacks 12.21.10 | 09:12 am
- Acura Pharmaceuticals Named in Purported Class Action Securities Litigation (ACUR) - Benzinga 09.13.10 | 09:09 am
- Zacks Analyst Blog Highlights: Sprint Nextel, Verizon, AT&T, King Pharmaceuticals, Inc. and Acura Pharmaceuticals, Inc. - Press Releases - Zacks 04.27.10 | 07:04 am
- U.S. FDA advisory meetings through June 18 - Reuters 04.26.10 | 03:04 pm
